CLINICAL_TRIALS
trial_result
· 2022-01-28
Clinical Trial Update: A Phase II Study of HY209 Gel for Atopic Dermatitis Patients (Shaperon) [Phase 2]
Summary
Phase II study of HY209 gel for atopic dermatitis completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shaperon | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED